Biomarkers and Personalized Medicine
12.3K views | +0 today
Follow
Biomarkers and Personalized Medicine
Sharing relevant articles on advancements in personalized medicine
Curated by Brian Shields
Your new post is loading...
Your new post is loading...
Scooped by Brian Shields
Scoop.it!

A surfeit of riches in CLL and NHL: on bruton kinase and PI3K delta inhibitors

A surfeit of riches in CLL and NHL: on bruton kinase and PI3K delta inhibitors | Biomarkers and Personalized Medicine | Scoop.it

Great update by Sally Church from a conference on PI3K with updates on the PI3K-Akt-mTOR pathway in depth.

more...
No comment yet.
Scooped by Brian Shields
Scoop.it!

Biovest's Personalized Cancer Vaccine Targeting Non-Hodgkin's Lymphoma ... - MarketWatch (press release)

Biovest's Personalized Cancer Vaccine Targeting Non-Hodgkin's Lymphoma ... - MarketWatch (press release) | Biomarkers and Personalized Medicine | Scoop.it
Biovest's Personalized Cancer Vaccine Targeting Non-Hodgkin's Lymphoma ...MarketWatch (press release)Biovest also reported the Company is scheduled to present at the 7th Annual Burrill Personalized Medicine Meeting at the San Francisco Airport...
more...
No comment yet.
Scooped by Brian Shields
Scoop.it!

#ASH11 Update #2 - Lymphomas - NHL, CLL, MCL | Pharma Strategy Blog

#ASH11 Update #2 - Lymphomas - NHL, CLL, MCL | Pharma Strategy Blog | Biomarkers and Personalized Medicine | Scoop.it
Overview of interesting pipeline data from #ASH11 in lymphomas including PCI-32765, BTK inhibitors, PI3K, CD20 antibodies, GA101, obinutuzumab and CAL-101...
more...
No comment yet.
Scooped by Brian Shields
Scoop.it!

Circulating Soluble CD30 and Future Risk of Lymphoma; Evidence from Two Prospective Studies in the General Population

Background: Elevated circulating soluble CD30 (sCD30) has been previously associated with AIDS-related non-Hodgkin lymphoma (NHL) risk.
more...
No comment yet.